Cargando…
DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation
Lung transplantation remains the treatment of choice for end-stage lung diseases, and recipient selection is currently based on clinical urgency, ABO compatibility, and donor size. The risk of allosensitization is classically based on HLA mismatch, but eplet mismatch load is increasingly seen to be...
Autores principales: | González-López, Elena, Mora-Cuesta, Víctor M., Roa-Bautista, Adriel, Comins-Boo, Alejandra, Renaldo, André, Irure-Ventura, Juan, Iturbe-Fernández, David, Tello-Mena, Sandra, San Segundo, David, Cifrián-Martínez, José, López-Hoyos, Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306436/ https://www.ncbi.nlm.nih.gov/pubmed/37389015 http://dx.doi.org/10.1097/TXD.0000000000001513 |
Ejemplares similares
-
Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
por: Hiho, Steven J., et al.
Publicado: (2022) -
The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016) -
Lung Transplant Candidates With Pretransplant Gastroesophageal Reflux and Antibodies to Lung Self-antigens Have Shorter CLAD-free Survival After Transplant
por: Razia, Deepika, et al.
Publicado: (2022) -
Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load
por: González-López, Elena, et al.
Publicado: (2023) -
Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic
por: Comins-Boo, Alejandra, et al.
Publicado: (2021)